Publication bias is a notable concern in nephrology research, especially for topics with industry-sponsored trials, such as novel phosphate binders or sodium-glucose co-transporter-2 (SGLT2) inhibitors for chronic kidney disease (CKD). This evidence concerns the gene SLC5A2 and chronic kidney disease.